Quinvax, a quinquevalent vaccine, to receive world top product award.

Published: 2007-08-21 06:57:00

Updated: 2007-08-21 06:57:00

Berna Biotech Korea Corp., a subsidiary of Crucell NV, a bio-engineering company of Netherlands, recently introduced Quinvaxem, a fully-liquid vaccine for protection against five important childhood diseases, which was selected as "The world top commodity" by the Ministry of Industry and Energy (...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK